The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials
2020 Dec 14.
Online ahead of print.
Franklin G Miller
Department of Bioethics, The Clinical Center, National Institutes of Health, Bethesda, Maryland.
Center for Communicable Disease Dynamics, Department of Epidemiology, Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Weill Cornell Medical College, New York, New York.
No abstract available